CPT code 95873 denotes the use of electrical stimulation to localize specific nerves prior to therapeutic or diagnostic injections. This procedure supports precise delivery of medications—such as local anesthetics or neurolytic agents—by identifying the nerve or nerve branch responsible for a patient’s symptoms. Nationally, accurate nerve localization affects clinical outcomes, procedural efficiency, and billing classification for interventional pain management and related services.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and common sites of service, alongside benchmarking metrics where available, payer coverage considerations, and recent policy or coding clarifications affecting use of this code. The content also highlights common modifiers and administrative notes relevant to claims processing.

This summary is intended for clinicians, billing professionals, and policy analysts seeking a clear, national-level briefing on the clinical purpose of CPT code 95873, typical care settings, and the aspects of payer coverage and coding practice that most influence reimbursement and compliance.